DEVELOPMENT OF ANTISENSE DRUG TARGETING PCSK9

被引：0
|
作者：
Harada-Shiba, M. [1 ]
Wada, F. [1 ]
Tachibana, K. [2 ]
Yamamoto, T. [2 ]
Kobayashi, T. [2 ]
机构：
[1] Natl Cerebral & Cardiovasc Ctr Res Inst, Suita, Osaka, Japan
[2] Osaka Univ, Suita, Osaka, Japan
来源：
ATHEROSCLEROSIS | 2018年 / 275卷
关键词：
D O I：
10.1016/j.atherosclerosis.2018.06.897
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
W4:4
引用
收藏
页码：E4 / E5
页数：2
相关论文
共 50 条
  • [21] Targeting PCSK9 to reduce residual risk in ACS
    Fernández-Ruiz I.
    Nature Reviews Cardiology, 2019, 16 (1) : 2 - 2
  • [22] Monoclonal Antibodies for the Treatment of Hypercholesterolemia: Targeting PCSK9
    Alkindi, Manal
    Siminovitch, Katherine A.
    Gupta, Milan
    Genest, Jacques
    CANADIAN JOURNAL OF CARDIOLOGY, 2016, 32 (12) : 1552 - 1560
  • [23] LONG TERM EFFECT OF BRIDGED NUCLEIC ACID (BNA)-BASED ANTISENSE TARGETING PCSK9 ON METABOLISM AND INFLAMMATION
    Harada-Shiba, M.
    Yamamoto, T.
    Yasuhara, H.
    Wada, F.
    Wada, S.
    Shibata, M.
    Obika, S.
    ATHEROSCLEROSIS, 2014, 235 (02) : E255 - E255
  • [24] BINDING OF PCSK9 TO CIRCULATING LDL: EFFECT OF PCSK9 MONOCLONAL ANTIBODIES ON THE LDL-BOUND PCSK9?
    De Stefano, D.
    Baragetti, A.
    Baragetti, A.
    Macri, N.
    Tavori, H.
    Fazio, S.
    Catapano, A. L.
    ATHEROSCLEROSIS, 2018, 275 : E101 - E101
  • [25] Targeting PCSK9 inhibitors to those who will benefit most
    Turner, Traci A.
    Stein, Evan A.
    LANCET DIABETES & ENDOCRINOLOGY, 2022, 10 (05): : 301 - 303
  • [26] Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
    Catarina R. Almeida
    Beatriz H. Ferreira
    Iola F. Duarte
    Signal Transduction and Targeted Therapy, 6
  • [27] Targeting PCSK9: a promising adjuvant strategy in cancer immunotherapy
    Almeida, Catarina R.
    Ferreira, Beatriz H.
    Duarte, Iola F.
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2021, 6 (01)
  • [28] Inclisiran RNAi therapeutic targeting PCSK9 Treatment of hypercholesterolemia
    Paton, D. M.
    DRUGS OF THE FUTURE, 2017, 42 (06) : 335 - 343
  • [29] PCSK9 inhibitors
    Farnier, Michel
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (03): : 66 - 70
  • [30] Advances in targeting LDL cholesterol: PCSK9 inhibitors and beyond
    Safarova, Maya
    Bimal, Tia
    Soffer, Daniel E.
    Hirsh, Benjamin
    Shapiro, Michael D.
    Mintz, Guy
    Cha, Agnes
    Gianos, Eugenia
    AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2024, 19
12345